biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Really sad!

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Jun 29, 2022 4:00pm

177 Views

Post# 34791648

RE:Really sad!

Ronrydell, how long have you been reading the BTI board? My guess not very long.

Not like myself who has been here for close to 10 years.

I cannot speak for the other posters here but JD is just getting back what he dished out to me over all these years! And besides even if you were around as long as I was you would not have access to all the pms between us. JD reaps what he sows!

I told everyone here you included many times over many years.

It's called " the IGNORE " button. USE IT!! Too simple!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages